Catalent Launches Accelerated U.S. Gene-to-Drug Substance Program for Complex Biologics Catalent, Inc., a global contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, has announced the U.S. launch of…
I2Pure Expands Leadership and Scientific Team to Support Molecular Iodine Manufacturing and Research Growth I2Pure Corp., a biotechnology company focused on patented molecular iodine (I₂) technology for antimicrobial and antiseptic…
Alliance Foundation Trials and Natera Launch Phase III NAVIGATE Trial to Evaluate MRD-Guided Breast Cancer Treatment Alliance Foundation Trials, LLC (AFT), a national organization focused on advancing innovative and practice-changing…
Bayer Plans $2.2 Billion Pharmaceutical Manufacturing Investment in Ohio Bayer has announced plans to invest approximately $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, marking one…
Roquette to Showcase Pharmaceutical Excipients and Drug Delivery Solutions at CPHI Milan 2026 Roquette, a global provider of pharmaceutical excipients, drug delivery technologies and biopharmaceutical solutions, will showcase its broad…
Pfizer Reports Positive Phase 3 Results for LITFULO in Nonsegmental Vitiligo Pfizer Inc. (NYSE: PFE) has announced detailed results from two Phase 3 clinical trials evaluating LITFULO® (ritlecitinib) as a…
Travere to Present New FILSPARI Data in IgA Nephropathy and FSGS at ASN Kidney Week 2026 Travere Therapeutics, Inc. (Nasdaq: TVTX) is set to present nine new data analyses, including…
Singleton Associates and Blue Cross and Blue Shield of Texas Reach Multi-Year Agreement to Maintain In-Network Radiology Access Singleton Associates, P.A. (Singleton Associates), a radiology practice affiliated with Radiology Partners,…
GeneDx to Launch Easy Order at 2026 AAP Conference to Simplify Genomic Testing for Pediatricians GeneDx, a company focused on rare disease diagnosis and improving health through genomic data, will…
Orano Med Inaugurates ATLab Valenciennes, Europe’s First Industrial-Scale Facility for Lead-212 Targeted Alpha Therapies Orano Med, a subsidiary of the Orano Group and a pioneer in targeted alpha therapies for…
ILiAD Biotechnologies Publishes Phase 2b SUPER Trial Results for Intranasal Pertussis Vaccine Candidate BPZE1 in The Lancet Infectious Diseases ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical-stage biotechnology company focused on…
Verastem Oncology Presents New Data Supporting Avutometinib Plus Defactinib Across Molecular Subgroups in Recurrent LGSOC Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company focused on developing new medicines for patients with…